Clinical Trial Update: [90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating [90Y]Y-PTT Endoradiotherapy for primary central nervous system lymphoma is currently recruiting, sponsored by Pentixapharm A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• [90Y]Y-PTT Endoradiotherapy

Snippet

Sponsor: Pentixapharm AG | Conditions: CNS Lymphoma | Phase 1, Phase 2 | Status: RECRUITING